Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population

por Piekarska, Anna, Koślińska-Berkan, Ewa, Wójcik, Kamila, Skubała, Anna, Jabłkowski, Maciej, Deroń, Zbigniew, Berkan-Kawińska, Aleksandra
Publicado 2016